Occlusion Balloon Catheter Market Size (2024 - 2029)

The occlusion balloon catheter market is anticipated to experience growth over the forecast period, driven by an increase in interventional cardiology demand due to rising cardiac disease prevalence. The pandemic initially led to a decline in non-COVID-19 medical procedures, but the subsequent rise in cardiac conditions among COVID-19 patients spurred market expansion. Additionally, market players focused on product development during the pandemic, contributing to market growth. Despite these positive trends, challenges such as the high cost of angioplasty procedures and a shortage of skilled professionals may hinder the market's expansion.

Market Size of Occlusion Balloon Catheter Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Occlusion Balloon Catheters Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 5.00 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Occlusion Balloon Catheter Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Occlusion Balloon Catheter Market Analysis

The occlusion balloon catheter market is expected to witness a CAGR of 5% during the forecast period.

Due to global lockdowns and suspended trade, there was a decline in medical diagnoses and health check-ups for non-COVID-19 patients, as healthcare activities were largely focused on COVID-19. For instance, as per the article published in the National Library of Medicine in September 2021, compared to the pre-pandemic period, the pandemic caused a significant decrease in the number of referrals and procedures completed. In addition, according to the same source, during the pandemic period, there was a marked decline in referrals and procedures carried out for cardiac procedures in Canada. Such a reduction in procedures led to a decline in patient visits to healthcare centers for intracardiac electrocardiography (ICE) procedures. However, there was an increase in various cardiac diseases during the later phase of the pandemic among COVID-19 patients, which, in turn, increased the demand for interventional cardiology. This contributed to considerable growth in the market studied.

Moreover, the global and regional players in the market studied focused more on product developments during the pandemic. For instance, BioSig Technologies Inc. presented data after successfully completing a blinded trial in 2021 for its PURE EP System. In August 2022, the company extended the commercialization of the product, a computerized system designed for collecting, digitizing, amplifying, filtering, measuring, and calculating electrocardiographic and intracardiac signals. It also records and stores the signals. Hence, development activities by major players during the pandemic period fueled the growth of the market studied.

Factors such as the increasing prevalence of cardiac diseases are expected to increase the market's growth. According to the 'Cardiovascular Diseases Statistics,' published by Eurostat in August 2021, cardiovascular disorders (CVDs) are the leading cause of mortality in Europe. They span various circulatory system-related medical conditions and place a considerable burden on healthcare systems and government budgets. Additionally, as per a press release by the European Society of Cardiology in September 2021, CVD caused 36% of all fatalities in Europe. In addition, as per the same source mentioned above, people of all ages are severely affected by CVD. In Europe, CVD is responsible for about 20% of all premature deaths (before the age of 65) annually.

Furthermore, as per the article published in the National Library of Medicine in February 2022, over the past 35 years, the prevalence of obesity has more than doubled. Additionally, as per the same source mentioned above, the middle-income European Society of Cardiology member countries face a high CVD burden with a projected incidence rate around 30% higher than those of high-income countries, and the disability-adjusted life years lost to CVD are about four times higher in middle-income countries than in high-income ones.

However, the high cost of angioplasty procedures and the dearth of skilled professionals are hampering the market's growth.

Occlusion Balloon Catheter Industry Segmentation

A balloon catheter is used in order to widen a narrow opening or passage within the body during a catheterization procedure. It is a type of "soft" catheter with an inflatable "balloon" at its tip. The deflated balloon catheter is put in place and inflated to carry out the required procedure, then deflated once more to be taken out. The device consists of a balloon and a catheter. The report covers the occlusion balloon catheters that are used in cardiac and peripheral interventions.

The occlusion balloon catheter market is segmented by material (latex, silicone, and other materials), indication (peripheral vascular diseases, coronary artery disease, and other indications), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers values in USD million for all the above-mentioned segments.

By Material
Latex
Silicone
Other Materials
By Indication
Peripheral Vascular Diseases
Coronary Artery Diseases
Other Indications
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Occlusion Balloon Catheter Market Size Summary

The occlusion balloon catheter market is poised for steady growth, driven by the increasing prevalence of cardiac diseases and advancements in medical technology. The market experienced a temporary setback during the pandemic due to a decline in non-COVID-19 medical procedures, but this was offset by a surge in demand for interventional cardiology as cardiac conditions rose among COVID-19 patients. Key industry players focused on product development and innovation during this period, contributing to market expansion. The rising incidence of cardiovascular diseases, particularly in Europe, and the growing geriatric population are expected to further propel market growth. However, challenges such as the high cost of angioplasty procedures and a shortage of skilled professionals may hinder progress.

North America is anticipated to maintain a significant market share, supported by a large patient pool, rapid technological advancements, and increased healthcare spending. The region's market growth is further bolstered by the prevalence of vascular diseases and congenital heart defects. The market is moderately fragmented, with major players like Boston Scientific Corp., Cook Group Incorporated, and Stryker Corporation actively engaging in new product developments and geographical expansion. Recent product launches, such as Abbott's Portico with FlexNav transcatheter aortic valve replacement system, highlight the ongoing innovation in the sector. These factors collectively suggest a positive outlook for the occlusion balloon catheter market over the forecast period.

Explore More

Occlusion Balloon Catheter Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Geriatric Population and Rising Prevalence of Cardiac Diseases

      2. 1.2.2 Increasing Disposable Income and Healthcare Spending

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Catheterization Procedures

      2. 1.3.2 The Dearth of Skilled Professionals and Risk of Infection

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Material

      1. 2.1.1 Latex

      2. 2.1.2 Silicone

      3. 2.1.3 Other Materials

    2. 2.2 By Indication

      1. 2.2.1 Peripheral Vascular Diseases

      2. 2.2.2 Coronary Artery Diseases

      3. 2.2.3 Other Indications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Occlusion Balloon Catheter Market Size FAQs

The Occlusion Balloon Catheter Market is projected to register a CAGR of 5% during the forecast period (2024-2029)

Boston Scientific Corp., Cook Group Incorporated, Stryker Corporation, W. L. Gore & Associates and Oscor, Inc. are the major companies operating in the Occlusion Balloon Catheter Market.

Occlusion Balloon Catheter Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)